| Particulars |
| Company Name |
Alivus Life Sciences Ltd |
| Face Value |
2 |
| BSE Code |
543322 |
| Year End |
202603 |
| Full Year |
| Equity (Rs in Cr.) |
24.55 |
| B.V. Rs |
271.40 |
| Sales Rs in Cr. |
2,551.83 |
| NP Rs in Cr. |
583.76 |
| NP Var% |
21.00 |
| Div% |
250.00 |
| CPS Rs |
53.70 |
| EPS Rs |
47.50 |
| Traded Value(Rs in Lakhs) |
325.08 |
| 52 Week High |
1,385.00 |
| 52 Week Low |
830.00 |
| Price BSE |
1,374.00 |
| Price NSE |
1,375.00 |
| Market Capital(Rs in Cr.) |
16,865.73 |
| P/C Ratio |
25.60 |
| P/E Ratio |
28.90 |
| Price Vs.BV |
5.06 |
| Latest Quarter |
| Year End |
202606 |
| Sales Rs in Cr. |
640.41 |
| NP Rs in Cr. |
160.08 |
| NP Var % |
32.00 |
| Trailing Twelve Months |
| Year End |
202606 |
| Sales |
2,204.90 |
| OPM |
28.73 |
| NP |
423.50 |
| NP Var% |
25.43 |
| EPS |
50.64 |
| PE |
27.13 |
|